Jedox joins the fight against blood cancer with DKMS

Freiburg, Germany, April 16, 2020 – Jedox, a leading provider of Enterprise Performance Management solutions, supports nonprofit organizations with donations each year. Jedox employees raised €1,000 Euros, which was then doubled by the company’s Board of Directors. This year, Jedox joined the fight against blood cancer with the nonprofit DKMS (German Bone Marrow Donor Center).

The annual fundraiser amongst Jedox staff has become a beloved tradition. After a successful fiscal year in 2019 which saw significant international growth for the company, the team wanted to pay it forward. In keeping with the Jedox motto “One Team,” the employees vote to select an organization they want to support. This year, Jedox selected DKMS, an international nonprofit organization dedicated to the fight against blood cancer and blood disorders.

Florian Winterstein, Jedox CEO and Lena Dierolf, Director of Global Marketing, hand over the check for 2,000 euros to Prof. Dr. Thomas Stieglitz, donating member at DKMS.

The DKMS offers registration for stem cell donors in many countries, including the US and UK, enables and promotes the further development of therapies against blood cancer, and supports patients through a variety of programs. The DKMS is dependent on monetary donations to continue its work. The costs for the registration of new donors are not covered by most health care systems. Each registration and laboratory evaluation costs 35 euros, which is roughly 38 USD. To ensure that this does not pose as a hurdle for potential donors, the organization covers this costs itself to improve the likelihood that patients in need can find a donor match.

Every 35 seconds, a person is diagnosed with blood cancer – and the greater the number of registered potential bone marrow donors, the greater the chance that suitable stem cells will be found to help treat patients. Learn more about the DKMS at www.dkms.de.